How do cancer therapies shape the epigenetic landscape of vascular cells, potentially giving rise to long-term vascular complications?

1.    To explore the response of long-non-coding RNAs to different anti-cancer agents.

2. To investigate the pivotal role these long-non-coding RNAs play in vascular remodeling during disease progression